ImmuneSpec BV
About
ImmuneSpec is a biotech service provider that offers high-sensitive immunopeptidomics/MAPPS/ligandomics analysis as a service. With our analysis we can identify maximized numbers of MHC I and MHC II associated peptides like neoantigens, tumor associated antigens (for development of immunotherapeutics & PM) but also pathogen derived antigens (for development of prophylactic vaccines) from biological samples. In the context of immunogenicity risk assessment we can deciphere potential T cell epitopes from biotherapeutics for the selection of safe, high efficacy biotherapeutics.
HEALTH SECTOR
Human healthAnimal healthOne health
RESEARCH AND DEVELOPMENT
Preclinical researchImmunotherapy developmentCell and Gene therapyVaccine developmentmRNA vaccines
THERAPEUTIC AREAS
Infectious diseasesOncologyImmunologyAutoimmune disordersRare diseasesRespiratory diseasesAllergiesCardiovascular diseasesNeurodegenerative diseasesTransplantation